Latin America and the Caribbean vs Saudi Arabia: Percentage of bloodstream infection due to methicillin-resistant
Latin America and the Caribbean
39.0%
in 2022
Saudi Arabia
52.0%
in 2022
Latin America and the Caribbean rank
10th
Saudi Arabia rank
12th
Percentage of bloodstream infection due to methicillin-resistant over time
- Latin America and the Caribbean
- Saudi Arabia
How they compare
Saudi Arabia currently reports 52.0% against 39.0% in Latin America and the Caribbean, a difference of 13.0%.
That makes Saudi Arabia's figure about 1.3 times Latin America and the Caribbean's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Latin America and the Caribbean ahead.
Latin America and the Caribbean ranks 10th and Saudi Arabia ranks 12th of 15 groups.
Saudi Arabia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latin America and the Caribbean | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 39.2% | 42.8% | 3.6% | Saudi Arabia |
| 2020s | 40.5% | 67.5% | 27.0% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Latin America and the Caribbean or Saudi Arabia?
- Saudi Arabia, at 52.0% against 39.0% in Latin America and the Caribbean as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Latin America and the Caribbean and Saudi Arabia?
- 13.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Latin America and the Caribbean and Saudi Arabia?
- 6 years are reported by both, from 2017 to 2022.
- How do Latin America and the Caribbean and Saudi Arabia rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Latin America and the Caribbean ranks 10th and Saudi Arabia ranks 12th of 15 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.